PCSK9 siRNA, on top of maximally tolerated statin therapy, potently lowers LDL-c

3' education - Nov. 16, 2019 - R. Scott Wright, MD, Rochester, MN, USA - AHA 2019, Philadelphia

Educational information

This video was recorded at the AHA in Philadelphia, USA, on november 16, 2019.

Faculty

R. Scott Wright, MD, is cardiologist at the Mayo Clinic in Rochester, USA.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Read our summary of the ORION-10 results

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.